Announcements Trials
Browse Landscape

Phase

Phase NA 1

Status

Withdrawn 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Other hematologic neoplasm 1Myeloid 1Classical hematology 1

Conditions

Anemia 4Neoplasms 2Leukemia, Myeloid, Acute 2Leukemia 2Hematologic Neoplasms 2Uterine Cervical Neoplasms 1Urinary Bladder Neoplasms 1Transfusion Reaction 1Thalassemia 1Precursor Cell Lymphoblastic Leukemia-Lymphoma 1Patient Participation 1Myelodysplastic Syndromes 1Multiple Myeloma 1Hemorrhage 1Carcinoma, Non-Small-Cell Lung 1Bronchiolitis Obliterans Syndrome 1Bone Marrow Failure Disorders 1Anemia, Sickle Cell 1Anemia, Aplastic 1

Interventions

fludarabine phosphate 7fludarabine 6Cyclophosphamide 5Whole-Body Irradiation 4Busulfan 4Antilymphocyte Serum 4Alemtuzumab 3Thiotepa 2Tacrolimus 2Peripheral Blood Stem Cell Transplantation 2Mycophenolic Acid 2Melphalan 2Clofarabine 2Bone Marrow Transplantation 2treosulfan 1thymoglobulin 1posaconazole 1eltrombopag 1X-Rays 1Therapeutics 1Specimen Handling 1Sirolimus 1Passive Cutaneous Anaphylaxis 1Morphine 1Methylprednisolone Hemisuccinate 1Methylprednisolone 1Methotrexate 1Methadone 1Hydromorphone 1Genetic Counseling 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Bone Marrow Failure Disorders × Blood Transfusion × Clear all
NCT03086252 2018-07-26

Patient-Driven Transfusion Thresholds in Hematological Disorders: A Pilot Study

Emory University

Phase NA Withdrawn
Classical hematologyMyeloidOther hematologic neoplasm

Bone Marrow Failure Disorders, Anemia, Anemia, Aplastic, Leukemia, Myelodysplastic Syndromes, Hematologic Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡